<DOC>
	<DOCNO>NCT00572260</DOCNO>
	<brief_summary>The goal study evaluate feasibility use daptomycin prophylactic antimicrobial agent patient undergoing cardiac surgery , determine rate surgical site infection , evaluate occurrence adverse event .</brief_summary>
	<brief_title>A Pilot Study Daptomycin Antimicrobial Prophylaxis</brief_title>
	<detailed_description />
	<mesh_term>Daptomycin</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients eligible inclusion study meet follow criterion : 1 . Provide sign date informed consent willing receive study medication 2 . Age ≥ 18 year age 3 . If female childbearing potential willing practice least one method birth control treatment least 28 day treatment study medication : 1. barrier method birth control ( e.g. , condom , diaphragms together spermicidal foam gel , presence IUD ) 2. surgical sterilization , approve hormonal contraceptive ( birth control pill , depoProvera , Lupron Depot ) , IUD acceptable . Rhythm , temperature , verbal promise abstinence acceptable method birth control . 4 . If female childbearing potential , serum HCG negative within 24 hour schedule surgery . 5 . Planned cardiac surgery procedure meet current Duke criterion receive antimicrobial prophylaxis active MRSA : . Patients meet least one follow criterion prophylaxis vancomycin : i. preoperative hospitalization &gt; 48 hour ii . transfer Duke outside facility iii . previous history MRSA iv . patient deem high risk MRSA attend surgeon , due complicate past medical and/or surgical history EXCLUSION CRITERIA : Patients satisfy follow eligible study enrollment . 1 . Hypersensitivity daptomycin 2 . Inability receive standard prophylaxis agent ( cefuroxime rifampin ) reason 3 . Staphylococcal bacteremia time enrollment 4 . Diagnosis S. aureus coagulase negative staphylococcus pacemaker/defibrillator infection within precede 18 month 5 . Patient undergoing emergency CABG 6 . Weight &gt; 150 kg &lt; 50kg 7 . Patients consider unlikely survive least 7 day due underlying illness . 8 . Patients creatinine clearance ( CLcr ) &lt; 30mL/min ( calculate use CockcroftGault equation use actual body weight ) 9 . Severe neutropenia ( absolute neutrophil count &lt; 0.500x103 /µL ) 10 . Pregnant , nurse lactate woman ( patient still childbearing potential , negative serum pregnancy test confirm ) 11 . Patients consider unlikely comply study procedure return schedule post treatment evaluation 12 . Any condition opinion investigator , would confound interfere evaluation safety efficacy investigational medication , prevent compliance study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>MRSA</keyword>
	<keyword>Increased risk infection</keyword>
</DOC>